Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration

Angelo Antonini, Stefano Goldwurm, Riccardo Benti, Holger Prokisch, Monika Ebhardt, Roberto Cilia, Michela Zini, Andrea Righini, Giovanni Cossu, Gianni Pezzoli

Research output: Contribution to journalArticlepeer-review

Abstract

We report on a patient with late-onset, pantothenate kinase-associated neurodegeneration (PKAN) who revealed two new heterozygous mutations at gene testing and showed asymmetric moderately reduced striatal dopamine transporter binding with single photon emission computed tomography, possibly due to prolonged neuroleptic treatment. These findings expand the genetic and imaging spectrum of this rare disorder.

Original languageEnglish
Pages (from-to)417-418
Number of pages2
JournalMovement Disorders
Volume21
Issue number3
DOIs
Publication statusPublished - Mar 2006

Keywords

  • DatSCAN/SPECT
  • Genetic
  • MRI
  • PKAN

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration'. Together they form a unique fingerprint.

Cite this